Expand CLYM Menu
CLYM MENU

CLYM Stock Posts


Unusual Option Volume

CLYM Climb Bio15.47+0.88 (+6.0%)

Climb Bio trades 4,317 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

CLYM Climb Bio14.53-0.52 (-3.5%)

Climb Bio trades 3,717 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026. News: Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
Unusual Option Volume

CLYM Climb Bio14.76-0.30 (-2.0%)

Climb Bio trades 2,916 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

CLYM Climb Bio15.88-0.20 (-1.2%)

Climb Bio trades 5,756 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

CLYM Climb Bio16.75-1.09 (-6.1%)

Climb Bio trades 3,030 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026.
Unusual Option Volume

CLYM Climb Bio17.53+1.13 (+6.9%)

Climb Bio trades 4,005 contracts. The company has the following event: PrisMN Phase 2 Trial Data Readout between Jul 1, 2026 and Dec 31, 2026.
Market Data Delayed 15 Minutes